StockData
Sionna Therapeutics, Inc. logo

Sionna Therapeutics, Inc. (SION) stock

SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$3.07−0.05 (-1.60%)

Close on Nov 17, 2026Market cap $138.80MP/E –Yield –

Sionna Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Sionna Therapeutics's total assets was $263.26M at Sep 30, 2026. For fiscal 2025 it was $325.95M, up 75.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$325.95M+75.5%
FY2024Dec 31, 2024$185.75M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$263.26M-22.4%
Q2 FY2026Jun 30, 2026$283.25M-19.5%
Q1 FY2026Mar 31, 2026$305.04M-17.5%
Q4 FY2025Dec 31, 2025$325.95M+75.5%
Q3 FY2025Sep 30, 2025$339.27M–
Q2 FY2025Jun 30, 2025$352.05M–
Q1 FY2025Mar 31, 2025$369.67M–
Q4 FY2024Dec 31, 2024$185.75M–

More Sionna Therapeutics figures

See a number that looks wrong?